Melanin-targeted [18F]-PFPN PET imaging may shed light for clear cell sarcoma

被引:3
作者
Zhang, Xiao [1 ,2 ,3 ]
Kang, Fei [4 ]
Zheng, Huaiyuan [5 ]
Gai, Yongkang [1 ,2 ]
Wang, Jing [4 ]
Lan, Xiaoli [1 ,2 ,3 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Nucl Med, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China
[2] Hubei Key Lab Mol Imaging, Wuhan 430022, Peoples R China
[3] Minist Educ, Key Lab Biol Targeted Therapy, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China
[4] Fourth Mil Med Univ, Xijing Hosp, Dept Nucl Med, 127 West Changle Rd, Xian, Peoples R China
[5] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hand Surg, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
F-18]-PFPN; Melanin; F-18]-FDG; PET/MRI; Clear cell sarcoma;
D O I
10.1007/s00259-023-06439-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose Intracytoplasmic melanin pigment is a characteristic of clear cell sarcoma (CCS), which is a particularly deadly type of soft-tissue sarcoma. [F-18]-N-(2-(diethylamino)ethyl)-5-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)picolinamide ([F-18]-PFPN) is a positron emission tomography (PET) probe characterized by high melanin affinity. Therefore, this study aimed to investigate the feasibility of melanin-targeted [F-18]-PFPN PET in patients with CCS.Methods This prospective single-centre study recruited patients with pathologically confirmed CCS. [F-18]-FDG PET/computed tomography and [F-18]-PFPN PET/magnetic resonance imaging scans were performed within 1 week of each other. The lesion numbers and [F-18]-FDG and [F-18]-PFPN PET parameters (maximum standardized uptake value [SUVmax], mean standardized uptake value [SUVmean], metabolic/melanotic tumour volume [MTV/MLTV], and total lesion glycolysis/melanin [TLG/TLM]) were collected.Results Three patients with CCS were recruited and received PET imaging. A total of 56 lesions were detected on [F-18]-PFPN PET, including primary tumour and distant metastases. Identical lesions were not detected on [F-18]-PFPN and [F-18]-FDG PET. Twelve lesions (12/39, 30.77%) on [F-18]-FDG imaging were missed on [F-18]-PFPN, and 20 lesions (20/47, 42.55%) on [F-18]-PFPN imaging were missed on [F-18]-FDG. In quantitative analysis, the [F-18]-FDG SUVmean (4.60 +/- 3.24) was higher than the [F-18]-PFPN SUVmean (3.0 +/- 2.63) in all lesions (P=0.01). No significant correlations were found between the SUVmax, SUVmean, MLTV/MTV, and TLM/TLG values of [F-18]-PFPN and [F-18]-FDG (P>0.05).Conclusion Melanin-targeted [F-18]-PFPN PET imaging is feasible for the diagnosis of CCS. Different imaging features were displayed on [F-18]-PFPN and [F-18]-FDG PET imaging, demonstrating the complementary role of the tracers. Combined use of the two imaging modalities would be preferred in patients with CCS.
引用
收藏
页码:196 / 201
页数:6
相关论文
共 6 条
  • [1] Melanin-targeted [18F]-PFPN PET imaging may shed light for clear cell sarcoma
    Xiao Zhang
    Fei Kang
    Huaiyuan Zheng
    Yongkang Gai
    Jing Wang
    Xiaoli Lan
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 51 : 196 - 201
  • [2] [18F]MEL050 as a melanin-targeted PET tracer: Fully automated radiosynthesis and comparison to 18F-FDG for the detection of pigmented melanoma in mice primary subcutaneous tumors and pulmonary metastases
    Rizzo-Padoin, Nathalie
    Chaussard, Michael
    Vignal, Nicolas
    Kotula, Ewa
    Tsoupko-Sitnikov, Vadim
    Vaz, Sofia
    Hontonnou, Fortune
    Liu, Wang-Qing
    Poyet, Jean-Luc
    Vidal, Michel
    Merlet, Pascal
    Hosten, Benoit
    Sarda-Mantel, Laure
    NUCLEAR MEDICINE AND BIOLOGY, 2016, 43 (12) : 773 - 780
  • [3] 18F-FDG PET/CT in Clear Cell Sarcoma With Multiple Bone Metastases
    Long, Tingting
    Hu, Shuo
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (06) : 566 - 568
  • [4] PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[18F]Fluoroglutamine
    Alyssa C. Pollard
    Vincenzo Paolillo
    Bhasker Radaram
    Sarah Qureshy
    Li Li
    Tapati Maity
    Lei Wang
    Md. Nasir Uddin
    Christopher G. Wood
    Jose A. Karam
    Mark D. Pagel
    David Piwnica-Worms
    Steven W. Millward
    Natalie Wall Fowlkes
    William Norton
    Brian J. Engel
    Federica Pisaneschi
    Niki M. Zacharias
    Molecular Imaging and Biology, 2022, 24 : 959 - 972
  • [5] Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F–Fluorodeoxyglucose (18F–FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study
    Christian Kelly-Morland
    Sarah Rudman
    Paul Nathan
    Susan Mallett
    Giovanni Montana
    Gary Cook
    Vicky Goh
    BMC Cancer, 17
  • [6] Hybrid [18F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): Preliminary results in non-small cell lung cancer (NSCLC)
    Heusch, Philipp
    Koehler, Jens
    Wittsack, Hans-Joerg
    Heusner, Till A.
    Buchbender, Christian
    Poeppel, Thorsten D.
    Nensa, Felix
    Wetter, Axel
    Gauler, Thomas
    Hartung, Verena
    Lanzman, Rotem S.
    EUROPEAN JOURNAL OF RADIOLOGY, 2013, 82 (11) : 2055 - 2060